LEADER 02608nam 2200685z- 450 001 9910557422303321 005 20231214133408.0 035 $a(CKB)5400000000043471 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69411 035 $a(EXLCZ)995400000000043471 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aActinobacteria and Myxobacteria$eImportant Resources for Novel Antibiotics 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 electronic resource (270 p.) 311 $a3-03943-529-9 311 $a3-03943-530-2 330 $aBacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum ?-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units. 517 $aActinobacteria and Myxobacteria 606 $aResearch & information: general$2bicssc 606 $aBiology, life sciences$2bicssc 610 $aactinomycetes 610 $aantibiotic biosynthesis 610 $asilent biosynthetic pathways 610 $a?-butyrolactones 610 $aHiTES 610 $atranslation inhibitors 610 $amarine actinobacteria 610 $aStreptomyces sp. 610 $aenzyme inhibition 610 $aantimicrobial 610 $aantioxidant 610 $acytotoxicity 610 $aGC-MS 610 $apyrrolopyrazines 610 $amyxobacteria 610 $aantivirals 610 $asecondary metabolites 610 $aHIV 610 $aEbola 610 $ahepatitis viruses 610 $adiversity 610 $auncultured 610 $anew antibiotics 610 $aStreptomyces 610 $apolyketides 610 $asecondary metabolite 610 $apolyketide synthases (PKSs) 615 7$aResearch & information: general 615 7$aBiology, life sciences 700 $aWink$b Joachim$4edt$01299261 702 $aWink$b Joachim$4oth 906 $aBOOK 912 $a9910557422303321 996 $aActinobacteria and Myxobacteria$93025090 997 $aUNINA